Cargando…

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course

BACKGROUND: It remains unclear whether disease course in multiple sclerosis (MS) is influenced by genetic polymorphisms. Here, we aimed to identify genetic variants associated with benign and aggressive disease courses in MS patients. METHODS: MS patients were classified into benign and aggressive p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gil-Varea, Elia, Urcelay, Elena, Vilariño-Güell, Carles, Costa, Carme, Midaglia, Luciana, Matesanz, Fuencisla, Rodríguez-Antigüedad, Alfredo, Oksenberg, Jorge, Espino-Paisan, Laura, Dessa Sadovnick, A., Saiz, Albert, Villar, Luisa M., García-Merino, Juan Antonio, Ramió-Torrentà, Lluís, Triviño, Juan Carlos, Quintana, Ester, Robles, René, Sánchez-López, Antonio, Arroyo, Rafael, Alvarez-Cermeño, Jose C., Vidal-Jordana, Angela, Malhotra, Sunny, Fissolo, Nicolas, Montalban, Xavier, Comabella, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138928/ https://www.ncbi.nlm.nih.gov/pubmed/30217166 http://dx.doi.org/10.1186/s12974-018-1307-1

Ejemplares similares

A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells
por: Gil-Varea, Elia, et al.
Publicado: (2020)

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients
por: Malhotra, Sunny, et al.
Publicado: (2018)

Polymorphisms in ARNTL/BMAL1 and CLOCK Are Not Associated with Multiple Sclerosis in Spanish Population
por: de Rojas, Isabel, et al.
Publicado: (2022)

Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease
por: Vilariño-Güell, Carles, et al.
Publicado: (2019)

Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis
por: Ortiz, Miguel A., et al.
Publicado: (2015)

Impact of Multiple Sclerosis Risk Polymorphism rs7665090 on MANBA Activity, Lysosomal Endocytosis, and Lymphocyte Activation
por: González-Jiménez, Adela, et al.
Publicado: (2022)

The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis
por: Gómez-Fernández, Paloma, et al.
Publicado: (2020)

Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis
por: Alcina, Antonio, et al.
Publicado: (2022)

Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis
por: Alcina, Antonio, et al.
Publicado: (2013)

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
por: Malhotra, Sunny, et al.
Publicado: (2015)

Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles
por: de la Hera, Belén, et al.
Publicado: (2014)

Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry
por: Meca-Lallana, J. E., et al.
Publicado: (2021)

Treatment with MOG-DNA vaccines induces CD4(+)CD25(+)FoxP3(+) regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis
por: Fissolo, Nicolás, et al.
Publicado: (2012)

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
por: Comabella, Manuel, et al.
Publicado: (2021)

Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6
por: Swaminathan, Bhairavi, et al.
Publicado: (2013)

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients
por: Sadovnick, A. Dessa, et al.
Publicado: (2016)

Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β
por: Bustamante, Marta F., et al.
Publicado: (2015)

Immunomodulatory Effects Associated with Cladribine Treatment
por: Fissolo, Nicolás, et al.
Publicado: (2021)

Genetic variation in NDFIP1 modifies the metabolic patterns in immune cells of multiple sclerosis patients
por: López-Cotarelo, Pilar, et al.
Publicado: (2021)

Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis
por: de la Hera, Belén, et al.
Publicado: (2014)

Disease-related knowledge measurement instruments of people affected by multiple sclerosis: protocol for a systematic psychometric review
por: Gonzalez-del-Rio, Marina, et al.
Publicado: (2021)

Multiple sclerosis in First Nations Canadians: A pilot comparison study
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022)

A comparison of genomic profiles of complex diseases under different models
por: Potenciano, Víctor, et al.
Publicado: (2016)

Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection
por: Alvarez Bravo, G., et al.
Publicado: (2020)

Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2
por: Álvarez Bravo, G., et al.
Publicado: (2020)

Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
por: Walo-Delgado, Paulette Esperanza, et al.
Publicado: (2021)

High ACSL5 Transcript Levels Associate with Systemic Lupus Erythematosus and Apoptosis in Jurkat T Lymphocytes and Peripheral Blood Cells
por: Catalá-Rabasa, Antonio, et al.
Publicado: (2011)

Genes and environment in multiple sclerosis: Impact of temporal changes in the sex ratio on recurrence risks
por: Sadovnick, A Dessa, et al.
Publicado: (2021)

The road to conception for women with multiple sclerosis
por: Sadovnick, Dessa, et al.
Publicado: (2021)

A Polymorphism Within the MBP Gene Is Associated With a Higher Relapse Number in Male Patients of Multiple Sclerosis
por: Espino-Paisán, Laura, et al.
Publicado: (2020)

An expert patient program to improve the empowerment and quality of life of people with multiple sclerosis: protocol for a multicenter pre-post intervention study
por: Robles-Sanchez, Miguel Angel, et al.
Publicado: (2023)

Clinical and radiological features of cerebral amyloid angiopathy-related inflammation
por: Bravo, Gary Álvarez, et al.
Publicado: (2021)

Ocrelizumab: a new milestone in multiple sclerosis therapy
por: Mulero, Patricia, et al.
Publicado: (2018)

CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS
por: Fissolo, Nicolás, et al.
Publicado: (2021)

NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity
por: Gharagozloo, Marjan, et al.
Publicado: (2019)

Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling
por: Valverde, Sergi, et al.
Publicado: (2015)

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis
por: Cantó, Ester, et al.
Publicado: (2014)

Interaction of PLP with GFP-MAL2 in the Human Oligodendroglial Cell Line HOG
por: Bello-Morales, Raquel, et al.
Publicado: (2011)

Splice-site variant in ACSL5: a marker promoting opposing effect on cell viability and protein expression
por: Pérez-Núñez, Iván, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0dagumb6r3p0dmu6mdim920mu5